124 related articles for article (PubMed ID: 15482527)
1. Many staging systems for hepatocellular carcinoma: evolution from Child-Pugh, Okuda to SLiDe.
Dohmen K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1227-32. PubMed ID: 15482527
[No Abstract] [Full Text] [Related]
2. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
[TBL] [Abstract][Full Text] [Related]
3. Controversies in staging of hepatocellular carcinoma.
Burns JM; Greene FL
J Hepatobiliary Pancreat Surg; 2005; 12(6):456-62. PubMed ID: 16365818
[TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408).
Vauthey JN; Pawlik TM; Lauwers GY; Nagorney DM; Roh MS; Curley SA; Poon RT; Belghiti J; Greene F; Michael Henderson J
Br J Surg; 2004 Aug; 91(8):1072. PubMed ID: 15286973
[No Abstract] [Full Text] [Related]
5. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy.
Seong J; Shim SJ; Lee IJ; Han KH; Chon CY; Ahn SH
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1037-42. PubMed ID: 17234356
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the hepatocellular carcinoma staging systems].
Um SH
Korean J Hepatol; 2006 Jun; 12(2):251-6. PubMed ID: 16804352
[No Abstract] [Full Text] [Related]
7. Staging systems for hepatocellular carcinoma: should we all use the BCLC system?
Marrero JA
J Hepatol; 2006 Apr; 44(4):630-2. PubMed ID: 16503077
[No Abstract] [Full Text] [Related]
8. [Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].
Kudo M; Chung H; Osaki Y; Kasugai H; Oka H; Seki T
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2100-4. PubMed ID: 15628751
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G
Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992
[TBL] [Abstract][Full Text] [Related]
10. Comparison of staging systems for HCC: one more positive answer or mission impossible?
Huo TI; Wu JC; Lee SD
Hepatology; 2005 Jul; 42(1):238-9. PubMed ID: 15962309
[No Abstract] [Full Text] [Related]
11. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
[TBL] [Abstract][Full Text] [Related]
13. Surgically resected hepatocellular carcinoma: protean yet predictable.
Vauthey JN; Lauwers GY
Ann Surg Oncol; 2005 Apr; 12(4):270-2. PubMed ID: 15827674
[No Abstract] [Full Text] [Related]
14. Comparison of staging systems to predict survival in hepatocellular carcinoma.
Pascual S; Zapater P; Such J; García-Herola A; Sempere L; Irurzun J; Palazón JM; Carnicer F; Pérez-Mateo M
Liver Int; 2006 Aug; 26(6):673-9. PubMed ID: 16842323
[TBL] [Abstract][Full Text] [Related]
15. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
16. Is the search for a single comprehensive staging system for hepatocellular carcinoma an elusive one?
McClune AC; Tong MJ
J Clin Gastroenterol; 2009 Sep; 43(8):697-8. PubMed ID: 19636257
[No Abstract] [Full Text] [Related]
17. Predicting survival in early hepatocellular carcinoma.
Ryder S
Gut; 2005 Mar; 54(3):328-9. PubMed ID: 15710977
[No Abstract] [Full Text] [Related]
18. Staging for liver cancer.
Daniele B; Perrone F
Clin Liver Dis; 2005 May; 9(2):213-23, vi. PubMed ID: 15831269
[TBL] [Abstract][Full Text] [Related]
19. Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma.
Gianni S; Cecchetto A; Altavilla G; Ragazzi R; Bertazzo M; De Giorgio M; Baldan A; Fagiuoli S; Farinati F
J Intern Med; 2005 Apr; 257(4):367-73. PubMed ID: 15788007
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of new prognostic staging systems (SLiDe score) for hepatocellular carcinoma patients who underwent hepatectomy.
Nanashima A; Omagari K; Sumida Y; Abo T; Fukuoha H; Takeshita H; Hidaka S; Tanaka K; Sawai T; Yasutake T; Nagayasu T; Mizuta Y; Ohba K; Ohnita K; Kadokawa Y
Hepatogastroenterology; 2009; 56(93):1137-40. PubMed ID: 19760957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
